Thymus longevity AI cancer immunity research 2026 | Healthcare Discovery
| | |

The AI Scientists Are Already Running the Lab: How Autonomous Multi-Agent Systems Are Reinventing Drug Discovery

A new generation of AI systems does not just assist scientists; it organizes itself into research teams, designs experiments, debates hypotheses, and identifies drug candidates at speeds no human laboratory…

Healthcare Discovery world's oldest person biology of extreme longevity showing supercentenarian multi-omics and healthy aging systems
| | |

What the World’s Oldest Person Reveals About the Biology of Extreme Longevity

A landmark Cell Reports Medicine study analyzed the genome, epigenome, microbiome, and metabolome of Maria Branyas Morera, the world’s oldest verified person. The findings reveal that extreme longevity results from…

Healthcare Discovery lipoprotein(a) RNA therapy cardiovascular risk 2026 showing inherited Lp(a) risk and RNA silencing in the liver
| | |

Lipoprotein(a) Is the Inherited Heart Attack Risk 1.4 Billion People Carry: Inside the RNA Therapies Racing to Silence It

Lipoprotein(a) is a genetically inherited cardiovascular risk factor that affects roughly one in five people worldwide and cannot be meaningfully lowered by statins, diet, or exercise. In 2026, a new…

Healthcare Discovery ARPA-H PROSPR program healthspan aging research showing federal clinical trials for healthy longevity
| | |

The U.S. Government Just Made Its Biggest Bet on Healthy Aging: Inside ARPA-H’s $144 Million PROSPR Program

ARPA-H’s $144 million PROSPR program is testing rapamycin, semaglutide, and dapagliflozin in 726 healthy older adults, funding a first-in-humans trial of a retrotransposon-silencing HIV drug, and building a validated biological…

The Daily Rounds: Longevity & Health Care Brief | April 5, 2026
| | | |

The Daily Rounds: Longevity & Health Care Brief | April 5, 2026

🧬 Cellular Reprogramming Enters Human Trials — Life Biosciences has launched the first FDA-approved partial de-aging trial, translating Sinclair's epigenetic reprogramming research from animal models to human medicine. 🧠 Gut-Brain Axis Reverses Memory Loss — Stanford's Nature study shows that correcting age-related gut bacteria shifts restores youthful cognitive performance by reactivating vagus nerve signaling to the hippocampus. 🤖 AI Drug Discovery Reaches Clinical Scale — 173+ AI-designed drug candidates are now in clinical trials, and longevity medicine is being advised to prepare for AI therapeutics to arrive in clinical practice imminently. 🦠 Gut Microbiome as Active Immune Regulator — New research reveals gut bacteria actively inject proteins into cells to modulate immunity, and a microbiome-derived molecule doubled lung cancer immunotherapy response rates in mice. 😴 Circadian Fragmentation Doubles Dementia Risk — A large Neurology journal study found that weak or late-peaking daily activity rhythms more than double the risk of dementia, making circadian optimization a key prevention target.

Alzheimer's blood-brain barrier nanoparticle research | Healthcare Discovery
| | |

Resistance Training Is Medicine for Your Brain: What 2026 Research Reveals About Strength Training, Depression, and Cognitive Decline

A growing body of clinical evidence shows that resistance training reduces depression symptoms as effectively as frontline medications, slows cognitive decline in aging adults, and triggers neurobiological changes that no…

Healthcare Discovery gut microbiome brain heart kidney axis 2026 research showing microbial signals connecting major organs
| | |

Your Gut Microbiome Is Talking to Your Brain, Heart, and Kidneys: Five 2026 Studies Reveal the Body’s Hidden Communication Network

A Stanford Nature study shows gut bacteria drive age-related memory loss through vagus nerve inflammation, while new research in Nature Communications, npj Biofilms and Microbiomes, and Microbiology Spectrum reveals that…